Results 21 to 30 of about 27,421 (247)

Association of Serum Osteoprotegerin Level With Myocardial Injury and Cardiovascular Calcification in Chronic Kidney Disease Patients

Frontiers in Medicine, 2022
BackgroundChronic kidney disease has emerged as a significant independent risk factor for cardiovascular disease. Cardiovascular calcification is an active process involving a complex interaction of inducers and inhibitors.
Kamal M. Okasha, Mohamed Hussein Aboufreikha, Waleed Elrefaey, Medhat M. Ashmawy, Heba Mourad, Mohamed A. Elsebaey, Mohammed H. Elnaggar, Raghda Gabr Mashaal, Sama Metwally, Shaimaa Samir Amin Mashal, Neveen A. Shalaby, Shireen Ali Elhoseny, Amr Alkassas, Mohammed Elbarbary, Osama Shoeib, Dina A. Ali, Nivin Baiomy, Sherein M. Alnabawy   +17 more
doaj   +1 more source

Osteoprotegerin in Cardiometabolic Disorders [PDF]

International Journal of Endocrinology, 2015
Osteoprotegerin (OPG), a glycoprotein traditionally implicated in bone remodelling, has been recently related to cardiovascular disease (CVD). Human studies show a positive relationship between circulating OPG, vascular damage, and CVD, and as such OPG has emerged as a potential biomarker for CVD.
Pérez de Ciriza, C., Lawrie, A., Varo, N.   +2 more
openaire   +5 more sources

SYNOVIAL AND SERUM LEVELS OF OSTEOCALCIN, OSTEOPROTEGERIN AND Β-CROSSLAPS IN PATIENTS WITH CALCIUM PYROPHOSPHATE DEPOSITION DISEASE [PDF]

Romanian Journal of Rheumatology, 2019
Background. Calcium pyrophosphate deposition disease is defined by deposition of calcium pyrophosphate crystals in hyaline cartilage, fibrocartilage and soft tissues. The study of bone markers is of great interest in different types of arthritis.
Paulina Vele, Ciprian N. Silaghi, Laura O. Damian, Siao-Pin Simon, Alexandra M. Craciun, Simona Rednic   +5 more
doaj   +1 more source

Osteoprotegerin Prevents Intracranial Aneurysm Progression by Promoting Collagen Biosynthesis and Vascular Smooth Muscle Cell Proliferation

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2020
Background Decreased extracellular matrix formation and few vascular smooth muscle cells (VSMCs) in cerebral vascular walls are the main characteristics of intracranial aneurysm (IA) pathogenesis.
Takeshi Miyata, Manabu Minami, Hiroharu Kataoka, Kosuke Hayashi, Taichi Ikedo, Tao Yang, Yu Yamamoto, Masayuki Yokode, Susumu Miyamoto   +8 more
doaj   +1 more source

Osteoprotegerin concentration and risk of cardiovascular outcomes in nine general population studies: Literature-based meta-analysis involving 26,442 participants. [PDF]

PLoS ONE, 2017
Recent experimental and epidemiological studies have suggested that osteoprotegerin, a key regulator in bone metabolism, may be involved in vascular calcification and atherosclerosis.
Lena Tschiderer, Johann Willeit, Georg Schett, Stefan Kiechl, Peter Willeit   +4 more
doaj   +1 more source

Association of Serum Osteoprotegerin Levels with Bone Loss in Chronic Kidney Disease: Insights from the KNOW-CKD Study.

PLoS ONE, 2016
Osteoprotegerin, a potent osteoclast activation inhibitor, decreases bone resorption and positively affects bone mineral density. This study examined the association between serum osteoprotegerin levels and bone loss in patients with chronic kidney ...
Chang Seong Kim, Eun Hui Bae, Seong Kwon Ma, Seung Hyeok Han, Kyu Hun Choi, Joongyub Lee, Dong Wan Chae, Kook-Hwan Oh, Curie Ahn, Soo Wan Kim, Representatives of the KNOW-CKD Investigator Group   +10 more
doaj   +1 more source

Associations of Bone Mineral Density with RANKL and Osteoprotegerin in Arab Postmenopausal Women: A Cross-Sectional Study

Medicina, 2022
Background and objective: There is limited information as to the association of several key bone markers with bone mineral density (BMD) in understudied ethnic groups. This study investigated the relationship between circulating levels of osteoprotegerin
Osama E. Amer, Kaiser Wani, Mohammed G. A. Ansari, Abdullah M. Alnaami, Naji Aljohani, Saba Abdi, Syed D. Hussain, Nasser M. Al-Daghri, Majed S. Alokail   +8 more
doaj   +1 more source

OSTEOPROTEGERIN AND BONE DENSITY [PDF]

Biomedical Papers, 2001
Aim of study was determine if a correlation exists between bone mass density and concentration of osteoprotegerin. We examined the group of 199 patients of mean age of 63 years. Of the group under study, 31 patients had normal bone density (T score > -1 and < 1) and 168 probands had osteopenia or osteoporosis (T < -1).
D, Stejskal, M, Zurek, J, Bartek, L, Jedelský, V, Růzicka   +4 more
openaire   +2 more sources

Serum Osteoprotegerin and Carotid Intima-Media Thickness Are Related to High Arterial Stiffness in Heart Failure with Reduced Ejection Fraction

Diagnostics, 2021
Arterial stiffness (AS) is a complex vascular phenomenon with consequences for central hemodynamics and left-ventricular performance. Circulating biomarkers have been associated with AS; however, their value in heart failure is poorly characterized.
Lajos Fehérvári, Attila Frigy, Lóránd Kocsis, István Adorján Szabó, Timea Magdolna Szabo, Melinda Urkon, Zita Jakó, Előd Ernő Nagy   +7 more
doaj   +1 more source

Interleukin-19 promotes bone resorption by suppressing osteoprotegerin expression in BMSCs in a lipopolysaccharide-induced bone loss mouse model

Bone & Joint Research, 2023
Aims: Osteoporosis is characterized by decreased trabecular bone volume, and microarchitectural deterioration in the medullary cavity. Interleukin-19 (IL-19), a member of the IL-10 family, is an anti-inflammatory cytokine produced primarily by ...
Zhicheng Dai, Yanan Chen, Enjun He, Hongjie Wang, Weihong Guo, Zhenkai Wu, Kai Huang, Qinghua Zhao   +7 more
doaj   +1 more source